Trinity Biotech PLC (TRIB)
2.065
-0.38
(-15.71%)
USD |
NASDAQ |
Jun 25, 16:00
2.065
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Cash from Financing (Quarterly): 18.85M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.85M |
| December 31, 2023 | -1.763M |
| September 30, 2023 | -2.431M |
| June 30, 2023 | -13.46M |
| March 31, 2023 | 1.608M |
| December 31, 2022 | -1.403M |
| September 30, 2022 | -2.372M |
| June 30, 2022 | 4.325M |
| March 31, 2022 | -12.87M |
| December 31, 2021 | -3.587M |
| September 30, 2021 | -0.726M |
| June 30, 2021 | -3.47M |
| March 31, 2021 | 1.764M |
| December 31, 2020 | -5.238M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 3.312M |
| March 31, 2020 | -0.79M |
| December 31, 2019 | -5.531M |
| September 30, 2019 | 1.515M |
| June 30, 2019 | -2.755M |
| March 31, 2019 | -0.758M |
| December 31, 2018 | -4.396M |
| September 30, 2018 | -12.04M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.434M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.993M |
| September 30, 2017 | -1.793M |
| June 30, 2017 | -6.122M |
| March 31, 2017 | -2.735M |
| December 31, 2016 | -5.029M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -6.999M |
| March 31, 2016 | -1.327M |
| December 31, 2015 | 2.045M |
| September 30, 2015 | -5.255M |
| June 30, 2015 | 110.73M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 3.603M |
| September 30, 2014 | -5.03M |
| June 30, 2014 | 1.05M |
| March 31, 2014 | -1.05M |
| December 31, 2013 | 3.575M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -4.373M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 1.127M |
| September 30, 2012 | -1.069M |
| June 30, 2012 | -5.24M |
| March 31, 2012 | -1.011M |
| December 31, 2011 | -1.025M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-13.46M
Minimum
Jun 2023
18.85M
Maximum
Mar 2024
-1.251M
Average
-1.583M
Median
Cash from Financing (Quarterly) Benchmarks
| Amarin Corp PLC | -1.426M |
| Avadel Pharmaceuticals PLC | 13.19M |
| Medtronic PLC | -2.359B |
| Perspective Therapeutics Inc | 166.33M |
| Xtant Medical Holdings Inc | 5.179M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.819M |
| Cash from Investing (Quarterly) | -13.96M |
| Free Cash Flow | -15.20M |
| Free Cash Flow Per Share (Quarterly) | -9.653 |
| Free Cash Flow to Equity (Quarterly) | -23.05M |
| Free Cash Flow to Firm (Quarterly) | -4.069M |
| Free Cash Flow Yield | -103.6% |